Population-based assessment of the incidence, risk factors, and outcomes of anaerobic bloodstream infections

Infection

Volumn 41, Issue 1, 2013, Pages 41-48

  Ngo, J T ^a   Parkins, M D ^a,b   Gregson, D B ^b,c   Pitout, J D D ^b,c   Ross, T ^b,c   Church, D L ^a,b,c   Laupland, K B ^a,b  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c CALGARY LABORATORY SERVICES   (Canada)

Author keywords

Anaerobe; Bacteremia; Bacteroides; Epidemiology; Mortality; Population

Indexed keywords

CLINDAMYCIN; METRONIDAZOLE; PENICILLIN DERIVATIVE;

ADULT; AGE; AGED; ANAEROBIC INFECTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEROIDES; BACTEROIDES FRAGILIS; BLOODSTREAM INFECTION; CANADA; CEREBROVASCULAR ACCIDENT; CHRONIC KIDNEY FAILURE; CHRONIC LIVER DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLOSTRIDIUM; CLOSTRIDIUM PERFRINGENS; COMMUNICABLE DISEASE; COMORBIDITY; DEATH; DIABETES MELLITUS; DISEASE SURVEILLANCE; EGGERTHELLA; ENTERITIS; ENTEROBACTERIACEAE; ENTEROCOCCUS; ESCHERICHIA COLI; FEMALE; FUSOBACTERIUM; HEALTHCARE ASSOCIATED INFECTION; HEART DISEASE; HIGH RISK POPULATION; HOSPITAL INFECTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFECTION RISK; LACTOBACILLUS; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEOPLASM; PEPTOSTREPTOCOCCUS; POPULATION RESEARCH; PREVOTELLA; PROPIONIBACTERIUM; RETROSPECTIVE STUDY; RISK FACTOR; SEX; STAPHYLOCOCCUS; STREPTOCOCCUS; VEILLONELLA;

ALBERTA; BACTEREMIA; BACTERIA, ANAEROBIC; BACTERIAL INFECTIONS; HUMANS; INCIDENCE; POPULATION SURVEILLANCE; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84873743452     PISSN: 03008126     EISSN: 14390973     Source Type: Journal    
DOI: 10.1007/s15010-012-0389-4     Document Type: Article

References (39)

1. Brook I. The role of anaerobic bacteria in bacteremia. Anaerobe. 2010;16:183-9.
2. Goldstein EJ. Anaerobic bacteremia. Clin Infect Dis. 1996;23(Suppl 1):S97-101.
3. Mandell G, Bennett J, Dolin R. Mandell, Douglas, and Bennett's principles and practice of infectious diseases. 7th ed. Philadelphia: Churchill Livingstone; 2009.
4. Lassmann B, Gustafson DR, Wood CM, Rosenblatt JE. Reemergence of anaerobic bacteremia. Clin Infect Dis. 2007;44:895-900.
5. Lombardi DP, Engleberg NC. Anaerobic bacteremia: incidence, patient characteristics, and clinical significance. Am J Med. 1992;92:53-60.
6. Bryan CS, Reynolds KL, Kirkhart B, Brown JJ. Bacteroides bacteremia. Analysis of 142 episodes from one metropolitan area. Arch Surg. 1984;119:894-8.
7. Muttaiyah S, Paviour S, Buckwell L, Roberts SA. Anaerobic bacteraemia in patients admitted to Auckland City Hospital: its clinical significance. N Z Med J. 2007;120:U2809.
8. Blairon L, De Gheldre Y, Delaere B, Sonet A, Bosly A, Glupczynski Y. A 62-month retrospective epidemiological survey of anaerobic bacteraemia in a university hospital. Clin Microbiol Infect. 2006;12:527-32.
9. Hung MN, Chen SY, Wang JL, et al. Community-acquired anaerobic bacteremia in adults: one-year experience in a medical center. J Microbiol Immunol Infect. 2005;38:436-43.
10. Zahar JR, Farhat H, Chachaty E, Meshaka P, Antoun S, Nitenberg G. Incidence and clinical significance of anaerobic bacteraemia in cancer patients: a 6-year retrospective study. Clin Microbiol Infect. 2005;11:724-9.
11. Leal J, Gregson DB, Ross T, Flemons WW, Church DL, Laupland KB. Development of a novel electronic surveillance system for monitoring of bloodstream infections. Infect Control Hosp Epidemiol. 2010;31:740-7.
12. Friedman ND, Kaye KS, Stout JE, et al. Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med. 2002;137:791-7.
13. Quan H, Sundararajan V, Halfon P, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005;43:1130-9.
14. Clinical and Laboratory Standards Institute (CLSI). Methods for antimicrobial susceptibility testing of anaerobic bacteria; Approved standard, 7th edition. CLSI document M11-A7. Wayne: CLSI; 2007.
15. Clinical and Laboratory Standards Institute (CLSI). Interpretive criteria for identification of bacteria and fungi by DNA target sequencing; Approved guideline. CLSI document MM18-A, vol. 28, no. 12. Wayne: CLSI; 2008.
16. Calgary Health Region. Health systems analysis: demographic data. Population by Alberta regional health authorities. Available at: http://www.calgaryhealthregion.ca. Accessed 1 Aug 2010.
17. Renaud B, Brun-Buisson C; ICU-Bacteremia Study Group. Outcomes of primary and catheter-related bacteremia. A cohort and case-control study in critically ill patients. Am J Respir Crit Care Med. 2001;163:1584-90.
18. Alberta Health Services. Health system analysis: demographic data. Available at: http://www.calgaryhealthregion.ca. Accessed 1 Aug 2010.
19. Southern Alberta Clinic. Epidemiology of HIV. Available at: http://www.albertahealthservices.ca/6250.asp. Accessed 1 Aug 2010.
20. Manns BJ, Mortis GP, Taub KJ, McLaughlin K, Donaldson C, Ghali WA. The Southern Alberta Renal Program database: a prototype for patient management and research initiatives. Clin Invest Med. 2001;24:164-70.
21. ALTRA Southern Alberta Transplant Program. Available at: http://www.albertahealthservices.ca/services.asp?pid=service&rid=1738. Accessed 1 Aug 2010.
22. Health Canada. Statistical report on the health of Canadians. Available at: http://www.statcan.gc.ca/pub/82-570-x/4064413-eng.htm. Accessed 01 Aug 2010.
23. Alberta Diabetes Surveillance System. Available at: http://www. albertadiabetes.ca. Accessed 1 Aug 2010.
24. Bernstein CN, Wajda A, Svenson LW, et al. The epidemiology of inflammatory bowel disease in Canada: a population-based study. Am J Gastroenterol. 2006;101:1559-68.
25. Marrett LD, Dep P, Airia P, Dryer D; Steering Committee of Canadian Cancer Statistics 2008. Cancer in Canada in 2008. CMAJ. 2008;179:1163-70.
26. Gabriel SE, Crowson CS, O'Fallon WM. The epidemiology of rheumatoid arthritis in Rochester, Minnesota, 1955-1985. Arthritis Rheum. 1999;42:415-20.
27. Papaparaskevas J, Katsandri A, Pantazatou A, et al. Epidemiological characteristics of infections caused by Bacteroides, Prevotella and Fusobacterium species: a prospective observational study. Anaerobe. 2011;17:113-7.
28. Salonen JH, Eerola E, Meurman O. Clinical significance and outcome of anaerobic bacteremia. Clin Infect Dis. 1998;26:1413-7.
29. Laupland KB. Population-based epidemiology of intensive care: critical importance of ascertainment of residency status. Crit Care. 2004;8:R431-6.
30. Paltiel O, Ronen I, Polliack A, Epstein L. Two-way referral bias: evidence from a clinical audit of lymphoma in a teaching hospital. J Clin Epidemiol. 1998;51:93-8.
31. Smith LD. Virulence factors of Clostridium perfringens. Rev Infect Dis. 1979;1:254-62.
32. McClane B. Clostridium perfringens type C isolates rapidly upregulate their toxin production upon contact with host cells: new insights into virulence? Virulence. 2010;1:97-100.
33. Robert R, Deraignac A, Le Moal G, Ragot S, Grollier G. Prognostic factors and impact of antibiotherapy in 117 cases of anaerobic bacteraemia. Eur J Clin Microbiol Infect Dis. 2008;27:671-8.
34. Nguyen MH, Yu VL, Morris AJ, et al. Antimicrobial resistance and clinical outcome of Bacteroides bacteremia: findings of a multicenter prospective observational trial. Clin Infect Dis. 2000;30:870-6.
35. Aldridge KE, Ashcraft D, O'Brien M, Sanders CV. Bacteremia due to Bacteroides fragilis group: distribution of species, beta-lactamase production, and antimicrobial susceptibility patterns. Antimicrob Agents Chemother. 2003;47:148-53.
36. Snydman DR, Jacobus NV, McDermott LA, et al. Lessons learned from the anaerobe survey: historical perspective and review of the most recent data (2005-2007). Clin Infect Dis. 2010;50(Suppl 1):S26-33.
37. Hecht DW. Anaerobes: antibiotic resistance, clinical significance, and the role of susceptibility testing. Anaerobe. 2006;12:115-21.
38. Davies HD, McGeer A, Schwartz B, et al. Invasive group A streptococcal infections in Ontario, Canada. Ontario Group A Streptococcal Study Group. N Engl J Med. 1996;335:547-54.
39. Farley MM, Harvey RC, Stull T, et al. A population-based assessment of invasive disease due to group B Streptococcus in nonpregnant adults. N Engl J Med. 1993;328:1807-11.